Filing Flows

Filing Flows › Companies › Adia Med › Cash flow

Adia Med cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$109K in Q2 2026 · −$181K over twelve months

Operating cash flow−$109K
Capital spending−$1
Free cash flow−$109K
Cash / net income-2.7×

Analysis

In Q2 2026, Adia Med generated −$109K of operating cash flow and spent $1 on capital projects, leaving free cash flow of −$109K. That is $41K more than in Q2 2025 (−$150K).

Over the twelve months to Jun 30, 2026, operating cash flow was −$176K; the largest uses were operating cash flow ($176K), other investing ($21K), other financing ($20K); besides operations, cash came from net borrowing (+) / repaid (−) ($235K); the cash balance rose by $13K.

Operating cash flow was −$109K against net income of $40K — -2.7× profit, less cash than reported earnings, worth checking against working capital. The largest differences: deferred revenue −$154K, receivables +$35K, payables −$23K.

Free cash flow

Adia Med: free cash flow by quarterAdia Med: free cash flow by quarter−$31KQ1 2025−$150KQ2 2025−$61KQ1 2026−$109KQ2 2026
Operating cash flow less capital spending.
Adia Med: operating cash flow against capital spendingAdia Med: operating cash flow against capital spendingOperating cash flowCapital spending−$31K$0Q1 2025−$136K$13KQ2 2025−$55K$5KQ1 2026−$109K$1Q2 2026
Latest (Q2 2026): Operating cash flow −$109K, Capital spending $1.

Cash runway and the debt wall

Cash & investments$79K
Debtnone
Net cash$79K
Cash runway5 months

Adia Med is burning cash: its operations consume cash, a free cash flow of −$181K a year at the current rate against $79K of cash and investments: a runway of about 5 months before any new financing.

Where the cash came from and went

Adia Med: sources (+) and uses (−) of cash, Q2 2026Adia Med: sources (+) and uses (−) of cash, Q2 2026Net borrowing (+) / repaid (−)$112KOperating cash flow−$109KCash drawn (+) / kept (−)$9KOther financing−$6KOther investing−$5KCapital spending−$1
Adia Med: sources (+) and uses (−) of cash, TTM to Q2 2026Adia Med: sources (+) and uses (−) of cash, TTM to Q2 2026Net borrowing (+) / repaid (−)$235KOperating cash flow−$176KOther investing−$21KOther financing−$20KCash drawn (+) / kept (−)−$13KCapital spending−$5K

From profit to cash

Adia Med: net income to operating cash flow, Q2 2026Adia Med: net income to operating cash flow, Q2 2026Net income$40KDepreciation & amortization$1KReceivables$35KPayables−$23KDeferred revenue−$154KPrepaid and other assets−$3KOperating cash flow−$109K
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Cash drawn (+) / kept (−)Free cash flow
Q2 2026−$109K−$1$112K$9K−$109K
Q1 2026−$55K−$5K$124K−$57K−$61K
Q2 2025−$136K−$13K$162K−$78K−$150K
Q1 2025−$31K—$69K−$31K−$31K

Adia Med: income statement and cash flow

Adia Med, Q2 2026: revenue $485K (+311% year over year), operating margin 10.7%. The chart follows the revenue to costs, profit and cash.

Adia Med: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.